Factors predicting local or systemic side effects related to intravesical BCG (Bacillus Calmette-Guerin) therapy: a retrospective observational study.

ABSTRACT:

Objective

Intravesical BCG treatment is the most frequently preferred adjuvant treatment option with its effective results in non-muscle invasive bladder tumors. Despite effective results, systemic and local side effects can be observed and can be one of the main reasons for treatment discontinuation. In this study we aimed to identify clinical factors predicting BCG-related side effects during intravesical BCG therapy in patients with non-muscle invasive bladder cancer.

Methods

Demographic and clinical data of patients who received intravesical adjuvant BCG therapy for non-muscle invasive bladder tumor were obtained from patient records. Data on side effects following intravesical BCG therapy and clinical approaches were collected. After creating the patient sample, binary

SUBMITTER: Aksakalli T 

PROVIDER: S-EPMC11900595 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature